Literature DB >> 27717268

Taking the depressed "person" into account before moving into personalized or precision medicine.

Koen Demyttenaere1.   

Abstract

Entities:  

Year:  2016        PMID： 27717268      PMCID： PMC5032494          DOI： 10.1002/wps.20362

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

Review 1.  Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Authors:  Mark Sinyor; Anthony J Levitt; Amy H Cheung; Ayal Schaffer; Alex Kiss; Yekta Dowlati; Krista L Lanctôt
Journal:  J Clin Psychiatry       Date:  2010-01-26       Impact factor: 4.384

2.  Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group.

Authors:  Justin A Chen; George I Papakostas; Soo Jeong Youn; Lee Baer; Alisabet J Clain; Maurizio Fava; David Mischoulon
Journal:  J Clin Psychiatry       Date:  2011-10-04       Impact factor: 4.384

3.  Satisfaction with medication is correlated with outcome but not persistence in patients treated with placebo, escitalopram, or serotonin-norepinephrine reuptake inhibitors: a post hoc analysis.

Authors:  Koen Demyttenaere; Elin Heldbo Reines; Sara Larsson Lönn; Malcolm Lader
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  What is important in being cured from depression? Discordance between physicians and patients (1).

Authors:  Koen Demyttenaere; Anne-Françoise Donneau; Adelin Albert; Marc Ansseau; Eric Constant; Kees van Heeringen
Journal:  J Affect Disord       Date:  2014-12-10       Impact factor: 4.839

5.  Profitable failure: antidepressant drugs and the triumph of flawed experiments.

Authors:  Linsey McGoey
Journal:  Hist Human Sci       Date:  2010       Impact factor: 0.690

6.  Abandoning personalization to get to precision in the pharmacotherapy of depression.

Authors:  Roy H Perlis
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

7.  "Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.

Authors:  Koen Demyttenaere; Anne Verhaeghen; Nicolas Dantchev; Luigi Grassi; Angel L Montejo; David G S Perahia; Deborah Quail; Catherine Reed; Andre Tylee; Michael Bauer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

8.  Which factors influence psychiatrists' selection of antidepressants?

Authors:  Mark Zimmerman; Michael Posternak; Michael Friedman; Naureen Attiullah; Scott Baymiller; Robert Boland; Stacie Berlowitz; Shahzad Rahman; Kirsten Uy; Steve Singer
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

9.  What are 'good' depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis.

Authors:  Eiko I Fried; Sacha Epskamp; Randolph M Nesse; Francis Tuerlinckx; Denny Borsboom
Journal:  J Affect Disord       Date:  2015-10-01       Impact factor: 4.839
  9 in total
  2 in total

Review 1.  Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.

Authors:  Chad A Bousman; Malcolm Forbes; Mahesh Jayaram; Harris Eyre; Charles F Reynolds; Michael Berk; Malcolm Hopwood; Chee Ng
Journal:  BMC Psychiatry       Date:  2017-02-08       Impact factor: 3.630

Review 2.  Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review.

Authors:  Andrea Fiorillo; Bernardo Carpiniello; Serafino De Giorgi; Silvestro La Pia; Giuseppe Maina; Gaia Sampogna; Edoardo Spina; Alfonso Tortorella; Antonio Vita
Journal:  Front Psychiatry       Date:  2018-10-11       Impact factor: 4.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.